Annual Operating Expenses
$773.21 M
+$41.82 M+5.72%
December 31, 2023
Summary
- As of February 7, 2025, IART annual total operating expenses is $773.21 million, with the most recent change of +$41.82 million (+5.72%) on December 31, 2023.
- During the last 3 years, IART annual operating expenses has risen by +$73.55 million (+10.51%).
- IART annual operating expenses is now -2.64% below its all-time high of $794.20 million, reached on December 31, 2019.
Performance
IART Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$208.39 M
-$20.56 M-8.98%
September 30, 2024
Summary
- As of February 7, 2025, IART quarterly total operating expenses is $208.39 million, with the most recent change of -$20.56 million (-8.98%) on September 30, 2024.
- Over the past year, IART quarterly operating expenses has increased by +$16.64 million (+8.68%).
- IART quarterly operating expenses is now -8.98% below its all-time high of $228.95 million, reached on June 30, 2024.
Performance
IART Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
IART Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.7% | +8.7% |
3 y3 years | +10.5% | +8.7% |
5 y5 years | -2.1% | +8.7% |
IART Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +5.7% | -9.0% | +21.4% |
5 y | 5-year | -2.6% | +10.5% | -9.0% | +49.8% |
alltime | all time | -2.6% | +5988.3% | -9.0% | +5853.9% |
Integra LifeSciences Holdings Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $208.39 M(-9.0%) |
Jun 2024 | - | $228.95 M(+12.9%) |
Mar 2024 | - | $202.87 M(+6.5%) |
Dec 2023 | $773.21 M(+5.7%) | $190.45 M(-0.7%) |
Sep 2023 | - | $191.75 M(-1.4%) |
Jun 2023 | - | $194.52 M(-1.0%) |
Mar 2023 | - | $196.49 M(+7.8%) |
Dec 2022 | $731.39 M(-2.1%) | $182.25 M(+6.1%) |
Sep 2022 | - | $171.70 M(-9.4%) |
Jun 2022 | - | $189.54 M(+0.9%) |
Mar 2022 | - | $187.91 M(-1.6%) |
Dec 2021 | $747.41 M(+6.8%) | $191.05 M(+2.7%) |
Sep 2021 | - | $185.95 M(-0.5%) |
Jun 2021 | - | $186.87 M(+1.8%) |
Mar 2021 | - | $183.53 M(-2.9%) |
Dec 2020 | $699.66 M(-11.9%) | $188.93 M(+6.2%) |
Sep 2020 | - | $177.88 M(+27.9%) |
Jun 2020 | - | $139.11 M(-28.2%) |
Mar 2020 | - | $193.75 M(-5.3%) |
Dec 2019 | $794.20 M(+0.5%) | $204.56 M(+3.8%) |
Sep 2019 | - | $197.16 M(+1.6%) |
Jun 2019 | - | $194.01 M(-2.2%) |
Mar 2019 | - | $198.47 M(-2.1%) |
Dec 2018 | $789.95 M(+11.6%) | $202.74 M(+1.9%) |
Sep 2018 | - | $198.93 M(-1.0%) |
Jun 2018 | - | $200.99 M(+7.3%) |
Mar 2018 | - | $187.28 M(-12.2%) |
Dec 2017 | $707.92 M(+34.2%) | $213.21 M(+28.1%) |
Sep 2017 | - | $166.44 M(+0.2%) |
Jun 2017 | - | $166.18 M(+2.5%) |
Mar 2017 | - | $162.09 M(+25.2%) |
Dec 2016 | $527.65 M(+10.7%) | $129.47 M(-1.1%) |
Sep 2016 | - | $130.91 M(-4.7%) |
Jun 2016 | - | $137.37 M(+5.8%) |
Mar 2016 | - | $129.90 M(+2.2%) |
Dec 2015 | $476.61 M(+11.9%) | $127.15 M(-2.4%) |
Sep 2015 | - | $130.30 M(+15.2%) |
Jun 2015 | - | $113.08 M(+6.6%) |
Mar 2015 | - | $106.07 M(+1.5%) |
Dec 2014 | $425.91 M(+11.5%) | $104.47 M(-1.9%) |
Sep 2014 | - | $106.52 M(-19.3%) |
Jun 2014 | - | $131.98 M(+6.5%) |
Mar 2014 | - | $123.94 M(+332.8%) |
Dec 2013 | $381.91 M(-13.7%) | $28.64 M(-75.3%) |
Sep 2013 | - | $115.88 M(-1.9%) |
Jun 2013 | - | $118.16 M(-0.9%) |
Mar 2013 | - | $119.23 M(+4.6%) |
Dec 2012 | $442.66 M(+3.9%) | $113.94 M(+2.8%) |
Sep 2012 | - | $110.80 M(-2.7%) |
Jun 2012 | - | $113.88 M(+9.4%) |
Mar 2012 | - | $104.04 M(-8.0%) |
Dec 2011 | $426.02 M(+16.7%) | $113.03 M(+7.4%) |
Sep 2011 | - | $105.24 M(-6.4%) |
Jun 2011 | - | $112.49 M(+18.1%) |
Mar 2011 | - | $95.25 M(-3.5%) |
Dec 2010 | $365.19 M | $98.67 M(+9.5%) |
Sep 2010 | - | $90.14 M(+0.7%) |
Jun 2010 | - | $89.55 M(+3.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2010 | - | $86.83 M(-5.3%) |
Dec 2009 | $339.75 M(-4.1%) | $91.73 M(+7.4%) |
Sep 2009 | - | $85.44 M(+4.2%) |
Jun 2009 | - | $82.02 M(+1.8%) |
Mar 2009 | - | $80.55 M(-0.9%) |
Dec 2008 | $354.37 M(+32.0%) | $81.26 M(-35.3%) |
Sep 2008 | - | $125.60 M(+69.2%) |
Jun 2008 | - | $74.24 M(+1.3%) |
Mar 2008 | - | $73.26 M(-8.0%) |
Dec 2007 | $268.50 M(+39.7%) | $79.67 M(+21.0%) |
Sep 2007 | - | $65.82 M(+1.2%) |
Jun 2007 | - | $65.06 M(+12.3%) |
Mar 2007 | - | $57.95 M(+7.7%) |
Dec 2006 | $192.24 M(+65.3%) | $53.80 M(-6.1%) |
Sep 2006 | - | $57.27 M(+25.6%) |
Jun 2006 | - | $45.59 M(+28.2%) |
Mar 2006 | - | $35.57 M(+14.9%) |
Dec 2005 | $116.29 M(-1.2%) | $30.96 M(+15.3%) |
Sep 2005 | - | $26.85 M(-10.9%) |
Jun 2005 | - | $30.12 M(+6.1%) |
Mar 2005 | - | $28.39 M(+13.7%) |
Dec 2004 | $117.75 M(+56.3%) | $24.96 M(-49.0%) |
Sep 2004 | - | $48.90 M(+111.0%) |
Jun 2004 | - | $23.18 M(+11.9%) |
Mar 2004 | - | $20.71 M(-17.5%) |
Dec 2003 | $75.36 M(+66.2%) | $25.09 M(+45.3%) |
Sep 2003 | - | $17.27 M(-0.5%) |
Jun 2003 | - | $17.36 M(+11.0%) |
Mar 2003 | - | $15.64 M(+71.6%) |
Dec 2002 | $45.34 M(+21.3%) | $9.11 M(-33.4%) |
Sep 2002 | - | $13.68 M(+19.1%) |
Jun 2002 | - | $11.49 M(+3.8%) |
Mar 2002 | - | $11.06 M(+22.5%) |
Dec 2001 | $37.39 M(-33.9%) | $9.03 M(-4.2%) |
Sep 2001 | - | $9.43 M(-2.0%) |
Jun 2001 | - | $9.62 M(-10.2%) |
Mar 2001 | - | $10.71 M(-58.2%) |
Dec 2000 | $56.55 M(+63.8%) | $25.60 M(+141.0%) |
Sep 2000 | - | $10.62 M(+15.4%) |
Jun 2000 | - | $9.20 M(+1.5%) |
Mar 2000 | - | $9.07 M(+16.0%) |
Dec 1999 | $34.52 M(+37.7%) | $7.82 M(-10.1%) |
Sep 1999 | - | $8.70 M(-7.4%) |
Jun 1999 | - | $9.40 M(+54.1%) |
Mar 1999 | - | $6.10 M(+9.5%) |
Dec 1998 | $25.07 M(-10.1%) | $5.57 M(-5.6%) |
Sep 1998 | - | $5.90 M(-10.6%) |
Jun 1998 | - | $6.60 M(-7.0%) |
Mar 1998 | - | $7.10 M(-44.1%) |
Dec 1997 | $27.90 M(+55.9%) | $12.70 M(+126.8%) |
Sep 1997 | - | $5.60 M(+9.8%) |
Jun 1997 | - | $5.10 M(+15.9%) |
Mar 1997 | - | $4.40 M(-4.3%) |
Dec 1996 | $17.90 M(+40.9%) | $4.60 M(+2.2%) |
Sep 1996 | - | $4.50 M(-6.3%) |
Jun 1996 | - | $4.80 M(+23.1%) |
Mar 1996 | - | $3.90 M(0.0%) |
Dec 1995 | $12.70 M | $3.90 M(+11.4%) |
Sep 1995 | - | $3.50 M |
FAQ
- What is Integra LifeSciences Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual operating expenses year-on-year change?
- What is Integra LifeSciences Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly operating expenses year-on-year change?
What is Integra LifeSciences Holdings annual total operating expenses?
The current annual operating expenses of IART is $773.21 M
What is the all time high annual operating expenses for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual total operating expenses is $794.20 M
What is Integra LifeSciences Holdings annual operating expenses year-on-year change?
Over the past year, IART annual total operating expenses has changed by +$41.82 M (+5.72%)
What is Integra LifeSciences Holdings quarterly total operating expenses?
The current quarterly operating expenses of IART is $208.39 M
What is the all time high quarterly operating expenses for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly total operating expenses is $228.95 M
What is Integra LifeSciences Holdings quarterly operating expenses year-on-year change?
Over the past year, IART quarterly total operating expenses has changed by +$16.64 M (+8.68%)